IBER.WS
Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS
IBER.WS
Delisted
IBER.WS was delisted on the 15th of February, 2023.
33 hedge funds and large institutions have $1.78M invested in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
33
Holding in Top 10
–
Calls
$2.29M
Puts
–
Top Sellers
| 1 | -$134K | |
| 2 | -$4K | |
| 3 | -$4K | |
| 4 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$2.22K |
| 5 |
PCM
Prelude Capital Management
New York
|
-$1K |